{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:06:12Z","timestamp":1780401972398,"version":"3.54.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T00:00:00Z","timestamp":1472083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Unwanted clots lead to heart attack and stroke that result in a large number of deaths. Currently available anticoagulants have some drawbacks including their non-specific actions. Therefore novel anticoagulants that target specific steps in the coagulation pathway are being sought. Here we describe the identification and characterization of a novel anticoagulant protein from the venom of <jats:italic>Hemachatus haemachatus<\/jats:italic> (African Ringhals cobra) that specifically inhibits factor X (FX) activation by the extrinsic tenase complex (ETC) and thus named as exactin. Exactin belongs to the three-finger toxin (3FTx) family, with high sequence identity to neurotoxins and low identity to the well-characterized 3FTx anticoagulants-hemextin and naniproin. It is a mixed-type inhibitor of ETC with the kinetic constants, Ki\u2019 and Ki determined as 30.62\u2009\u00b1\u20097.73\u2009nM and 153.75\u2009\u00b1\u200917.96\u2009nM, respectively. Exactin does not bind to the active site of factor VIIa and factor Xa based on its weak inhibition (IC<jats:sub>50<\/jats:sub>\u2009\u226b\u2009300\u2009\u03bcM) to the amidolytic activities of these proteases. Exactin shows exquisite macromolecular specificity to FX activation as compared to factor IX activation by ETC. Exactin thus displays a distinct mechanism when compared to other anticoagulants targeting ETC, with its selective preference to ETC-FX [ES] complex.<\/jats:p>","DOI":"10.1038\/srep32036","type":"journal-article","created":{"date-parts":[[2016,8,25]],"date-time":"2016-08-25T09:32:53Z","timestamp":1472117573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Exactin: A specific inhibitor of Factor X activation by extrinsic tenase complex from the venom of Hemachatus haemachatus"],"prefix":"10.1038","volume":"6","author":[{"given":"Vallerinteavide Mavelli","family":"Girish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Manjunatha","family":"Kini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,25]]},"reference":[{"key":"BFsrep32036_CR1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-0037-1615780","volume":"82","author":"KG Mann","year":"1999","unstructured":"Mann, K. G. Biochemistry and physiology of blood coagulation. Thromb. Haemost. 82, 165\u2013174 (1999).","journal-title":"Thromb. Haemost."},{"key":"BFsrep32036_CR2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","volume":"359","author":"B Furie","year":"2008","unstructured":"Furie, B. & Furie, B. C. Mechanisms of thrombus formation. N. Engl. J. Med. 359, 938\u2013949 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep32036_CR3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/ATVBAHA.108.162677","volume":"28","author":"PL Gross","year":"2008","unstructured":"Gross, P. L. & Weitz, J. I. New anticoagulants for treatment of venous thromboembolism. Arterioscler. Thromb. Vasc. Biol. 28, 380\u2013386 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep32036_CR4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrd1466","volume":"3","author":"D Gustafsson","year":"2004","unstructured":"Gustafsson, D. et al. A new oral anticoagulant: the 50-year challenge. Nat. Rev. Drug Discov. 3, 649\u2013659 (2004).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFsrep32036_CR5","first-page":"81","volume":"20","author":"HC Hemker","year":"1990","unstructured":"Hemker, H. C. & B\u00e9guin, S. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma. Haemostasis 20, 81\u201392 (1990).","journal-title":"Haemostasis"},{"key":"BFsrep32036_CR6","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1378\/chest.119.1_suppl.8S","volume":"119","author":"J Hirsh","year":"2001","unstructured":"Hirsh, J. et al. Oral anticoagulants: mechanism of action, clinical effectiveness and optimal therapeutic range. Chest 119, 8S\u201321S (2001).","journal-title":"Chest"},{"key":"BFsrep32036_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00007691-197901020-00001","volume":"1","author":"DA Triplett","year":"1979","unstructured":"Triplett, D. A. Heparin: biochemistry, therapy and laboratory monitoring. Ther. Drug Monit. 1, 173\u2013197 (1979).","journal-title":"Ther. Drug Monit."},{"key":"BFsrep32036_CR8","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1592\/phco.24.10.62S.36120","volume":"24","author":"D Hawkins","year":"2004","unstructured":"Hawkins, D. Limitations of traditional anticoagulants. Pharmacotherapy 24, 62S\u201365S (2004).","journal-title":"Pharmacotherapy"},{"key":"BFsrep32036_CR9","first-page":"635","volume":"59","author":"JD Horton","year":"1999","unstructured":"Horton, J. D. & Bushwick, B. M. Warfarin therapy: evolving strategies in anticoagulation. Am. Fam. Physician. 59, 635\u2013646 (1999).","journal-title":"Am. Fam. Physician."},{"key":"BFsrep32036_CR10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/asheducation-2013.1.464","volume":"2013","author":"KA Bauer","year":"2013","unstructured":"Bauer, K. A. Pros and cons of new oral anticoagulants. Hematology Am. Soc. Hematol. Educ. Program. 2013, 464\u2013470 (2013).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"BFsrep32036_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijcard.2016.03.056","volume":"214","author":"R Tummala","year":"2016","unstructured":"Tummala, R., Kavtaradze, A., Gupta, A. & Ghosh, R. K. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data. Int. J. Cardiol. 214, 292\u2013298 (2016).","journal-title":"Int. J. Cardiol."},{"key":"BFsrep32036_CR12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcmd.2005.12.034","volume":"36","author":"KJ Mann","year":"2006","unstructured":"Mann, K. J., Brummel-Ziedens, K., Orfeo, T. & Butenas, S. Models of blood coagulation. Blood Cells, Molecules and Diseases 36, 108\u2013117 (2006).","journal-title":"Blood Cells, Molecules and Diseases"},{"key":"BFsrep32036_CR13","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/ATVBAHA.107.148304","volume":"27","author":"RA Shirk","year":"2007","unstructured":"Shirk, R. A. & Vlasuk, G. P. Inhibitors of Factor VIIa\/tissue factor. Arterioscler. Thromb. Vasc. Biol. 27, 1895\u20131900 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFsrep32036_CR14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","volume":"338","author":"TJ Girard","year":"1989","unstructured":"Girard, T. J. et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338, 518\u2013520 (1989).","journal-title":"Nature"},{"key":"BFsrep32036_CR15","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1182\/blood-2001-12-0237","volume":"99","author":"IM Francischetti","year":"2002","unstructured":"Francischetti, I. M., Valenzuela, J. G., Andersen, J. F., Mather, T. N. & Ribeiro, J. M. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa\/tissue factor complex. Blood 99, 3602\u20133612 (2002).","journal-title":"Blood"},{"key":"BFsrep32036_CR16","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.92.13.6152","volume":"92","author":"M Cappello","year":"1995","unstructured":"Cappello, M., Vlasuk, G. P., Bergum, P. W., Huang, S. & Hotez, P. J. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc. Natl. Acad. Sci. 92, 6152\u20136156 (1995).","journal-title":"Proc. Natl. Acad. Sci"},{"key":"BFsrep32036_CR17","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.V80.12.3127.3127","volume":"80","author":"MM Fiore","year":"1992","unstructured":"Fiore, M. M., Neuenschwander, P. F. & Morrissey, J. H. An unusual antibody that blocks tissue factor\/factor VIIa function by inhibiting cleavage only of macromolecular substrates. Blood 80, 3127\u20133134 (1992).","journal-title":"Blood"},{"key":"BFsrep32036_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-0037-1612937","volume":"87","author":"L \u00d6rning","year":"2002","unstructured":"\u00d6rning, L. et al. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation. Thromb. Haemost. 87, 13\u201321 (2002).","journal-title":"Thromb. Haemost."},{"key":"BFsrep32036_CR19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.toxicon.2011.01.006","volume":"57","author":"T Sajevic","year":"2011","unstructured":"Sajevic, T., Leonardi, A. & Kri\u017eaj, I. Haemostatically active proteins in snake venoms. Toxicon 57, 627\u2013645 (2011).","journal-title":"Toxicon"},{"key":"BFsrep32036_CR20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/BJ20060302","volume":"397","author":"RM Kini","year":"2006","unstructured":"Kini, R. M. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem. J. 397, 377\u2013387 (2006).","journal-title":"Biochem. J."},{"key":"BFsrep32036_CR21","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/0041-0101(95)00103-4","volume":"33","author":"RM Kini","year":"1995","unstructured":"Kini, R. M. & Evans, H. J. The role of enzymatic activity in inhibition of the extrinsic tenase complex by phospholipase A2 isoenzymes from Naja nigricollis venom. Toxicon 33, 1585\u20131590 (1995).","journal-title":"Toxicon"},{"key":"BFsrep32036_CR22","doi-asserted-by":"crossref","first-page":"42601","DOI":"10.1074\/jbc.M508987200","volume":"280","author":"Y Banerjee","year":"2005","unstructured":"Banerjee, Y., Mizuguchi, J., Iwanaga, S. & Kini, R. M. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity. J. Biol. Chem. 280, 42601\u201342611 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.med.59.061606.095605","volume":"59","author":"U Hedner","year":"2008","unstructured":"Hedner, U. & Ezban, M. Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis. Annu. Rev. Med. 59, 29\u201341 (2008).","journal-title":"Annu. Rev. Med."},{"key":"BFsrep32036_CR24","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.2174\/138161207782023775","volume":"13","author":"Y Yamazaki","year":"2007","unstructured":"Yamazaki, Y. & Morita, T. Snake venom components affecting blood coagulation and the vascular system: structural similarities and marked diversity. Curr. Pharm. Des. 13, 2872\u20132886 (2007).","journal-title":"Curr. Pharm. Des"},{"key":"BFsrep32036_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/17474086.1.2.135","volume":"1","author":"CY Koh","year":"2008","unstructured":"Koh, C. Y. & Kini, R. M. Anticoagulants from hematophagous animals. Expert Rev. Hematol. 1, 135\u2013139 (2008).","journal-title":"Expert Rev. Hematol"},{"key":"BFsrep32036_CR26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/0005-2744(76)90330-2","volume":"429","author":"MC Boffa","year":"1976","unstructured":"Boffa, M. C. & Boffa, G. A. A phospholipase A2 with anticoagulant activity. II. Inhibition of the phospholiped activity in coagulation. Biochim. Biophys. Acta. 429, 839\u2013852 (1976).","journal-title":"Biochim. Biophys. Acta."},{"key":"BFsrep32036_CR27","doi-asserted-by":"crossref","first-page":"14402","DOI":"10.1016\/S0021-9258(18)47808-8","volume":"262","author":"RM Kini","year":"1987","unstructured":"Kini, R. M. & Evans, H. J. Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2. J. Biol. Chem. 262, 14402\u201314407 (1987).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR28","doi-asserted-by":"crossref","first-page":"25935","DOI":"10.1038\/srep25935","volume":"6","author":"B Barnwal","year":"2016","unstructured":"Barnwal, B., Jobichen, C., Girish, V. M., Foo, C. S., Sivaraman, J. & Kini, R. M. Ringhalexin from Hemachatus haemachatus: A novel inhibitor of extrinsic tenase complex. Sci Rep. 6, 25935 (2016).","journal-title":"Sci Rep"},{"key":"BFsrep32036_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0041-0101(80)90073-2","volume":"18","author":"FJ Joubert","year":"1980","unstructured":"Joubert, F. J. & Taljaard, N. The complete primary structure of toxin CM-1b from Hemachatus haemachatus (Ringhals) snake venom. Toxicon 18, 191\u2013198 (1980).","journal-title":"Toxicon"},{"key":"BFsrep32036_CR30","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1021\/acschembio.5b00492","volume":"10","author":"V Hassan-Puttaswamy","year":"2015","unstructured":"Hassan-Puttaswamy, V., Adams, D. J. & Kini, R. M. A Distinct Functional Site in \u03a9-Neurotoxins: Novel Antagonists of Nicotinic Acetylcholine Receptors from Snake Venom. ACS Chem Biol. 10, 2805\u20132815 (2015).","journal-title":"ACS Chem Biol"},{"key":"BFsrep32036_CR31","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1096\/fj.07-8658com","volume":"21","author":"N Rajagopalan","year":"2007","unstructured":"Rajagopalan, N., Pung, Y. F., Zhu, Y. Z., Wong, P. T., Kumar, P. P. & Kini, R. M. Beta-cardiotoxin: a new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity. FASEB J. 21, 3685\u20133695 (2007).","journal-title":"FASEB J"},{"key":"BFsrep32036_CR32","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1074\/jbc.M109.074161","volume":"285","author":"A Roy","year":"2010","unstructured":"Roy, A. et al. Structural and functional characterization of a novel homodimeric three-finger neurotoxin from the venom of Ophiophagus hannah (king cobra). J. Biol. Chem. 285, 8302\u20138315 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR33","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0049-3848(89)90056-X","volume":"55","author":"S Stefansson","year":"1989","unstructured":"Stefansson, S., Kini, R. M. & Evans, H. J. The inhibition of clotting complexes of the extrinsic coagulation cascade by the phospholipase A2 isoenzymes from Naja nigricollis venom. Thromb. Res. 55, 481\u2013491 (1989).","journal-title":"Thromb. Res."},{"key":"BFsrep32036_CR34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1538-7836.2004.01056.x","volume":"3","author":"RM Kini","year":"2005","unstructured":"Kini, R. M. & Banerjee, Y. Dissection approach: a simple strategy for the identification of the step of action of anticoagulant agents in the blood coagulation cascade. J. Thromb. Haemost. 3, 170\u2013171 (2005).","journal-title":"J. Thromb. Haemost."},{"key":"BFsrep32036_CR35","doi-asserted-by":"crossref","first-page":"28826","DOI":"10.1074\/jbc.M005266200","volume":"275","author":"RJ Baugh","year":"2000","unstructured":"Baugh, R. J., Dickinson, C. D., Ruf, W. & Krishnaswamy, S. Exosite interactions determine the affinity of factor X for the extrinsic Xase complex. J. Biol. Chem. 275, 28826\u201328833 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR36","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/bi000182+","volume":"39","author":"D Kirchhofer","year":"2000","unstructured":"Kirchhofer, D., Lipari, M. T., Moran, P., Eigenbrot, C. & Kelley, R. F. The tissue factor region that interacts with substrates factor IX and Factor X. Biochemistry 39, 7380\u20137387 (2000).","journal-title":"Biochemistry"},{"key":"BFsrep32036_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1389203023380675","volume":"3","author":"C Eigenbrot","year":"2002","unstructured":"Eigenbrot, C. Structure, function and activation of coagulation factor VII. Curr. Protein Pept. Sci. 3, 287\u2013299 (2002).","journal-title":"Curr. Protein Pept. Sci."},{"key":"BFsrep32036_CR38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/bj2650327","volume":"265","author":"VJ Bom","year":"1990","unstructured":"Bom, V. J. & Bertina, R. M. The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. Biochem. J. 265, 327\u2013336 (1990).","journal-title":"Biochem. J."},{"key":"BFsrep32036_CR39","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/bi00604a017","volume":"17","author":"GL Nelsestuen","year":"1978","unstructured":"Nelsestuen, G. L., Kisiel, W. & Di Scipio, R. G. Interaction of vitamin K dependent proteins with membranes. Biochemistry 17, 2134\u20132138 (1978).","journal-title":"Biochemistry"},{"key":"BFsrep32036_CR40","doi-asserted-by":"crossref","first-page":"26110","DOI":"10.1016\/S0021-9258(18)35724-7","volume":"267","author":"S Krishnaswamy","year":"1992","unstructured":"Krishnaswamy, S., Field, K. A., Edgington, T. S., Morrissey, J. H. & Mann, K. G. Role of the membrane surface in the activation of human coagulation factor X. J. Biol. Chem. 267, 26110\u201326120 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR41","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1016\/S0021-9258(18)45150-2","volume":"262","author":"EJ Husten","year":"1987","unstructured":"Husten, E. J., Esmon, C. T. & Johnson, A. E. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J. Biol. Chem. 262, 12953\u201312961 (1987).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR42","doi-asserted-by":"crossref","first-page":"30160","DOI":"10.1074\/jbc.272.48.30160","volume":"272","author":"CD McCallum","year":"1997","unstructured":"McCallum, C. D., Su, B., Neuenschwander, P. F., Morrissey, J. H. & Johnson, A. E. Tissue factor positions and maintains the factor VIIa active site far above the membrane surface even in the absence of the factor VIIa Gla domain. A fluorescence resonance energy transfer study. J. Biol. Chem. 272, 30160\u201330166 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR43","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/S0021-9258(18)52223-7","volume":"266","author":"W Ruf","year":"1991","unstructured":"Ruf, W., Rehemtulla, A., Morrissey, J. H. & Edgington, T. S. Phospholipid-independent and-dependent interactions required for tissue factor receptor and cofactor function. J. Biol. Chem. 266, 2158\u20132166 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR44","doi-asserted-by":"crossref","first-page":"49027","DOI":"10.1074\/jbc.M203091200","volume":"277","author":"K Soejima","year":"2002","unstructured":"Soejima, K. et al. The 99 and 170 loop-modified factor VIIa mutants show enhanced catalytic activity without tissue factor. J. Biol. Chem. 277, 49027\u201349035 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR45","doi-asserted-by":"crossref","first-page":"13988","DOI":"10.1021\/bi00043a004","volume":"34","author":"PF Neuenschwander","year":"1995","unstructured":"Neuenschwander, P. F., Bianco-Fisher, E., Rezaie, A. R. & Morrissey, J. H. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: enhancement of sensitivity to phosphatidylserine. Biochemistry 34, 13988\u201313993 (1995).","journal-title":"Biochemistry"},{"key":"BFsrep32036_CR46","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1073\/pnas.74.12.5260","volume":"74","author":"B \u00d8sterud","year":"1977","unstructured":"\u00d8sterud, B. & Rapaport, S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. 74, 5260\u20135264 (1977).","journal-title":"Proc. Natl. Acad. Sci"},{"key":"BFsrep32036_CR47","doi-asserted-by":"crossref","first-page":"11317","DOI":"10.1016\/S0021-9258(18)99165-9","volume":"266","author":"JH Lawson","year":"1991","unstructured":"Lawson, J. H. & Mann, K. G. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J. Biol. Chem. 266, 11317\u201311327 (1991).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1042\/bj2390757","volume":"239","author":"BJ Warn-Cramer","year":"1986","unstructured":"Warn-Cramer, B. J. & Bajaj, S. P. Intrinsic versus extrinsic coagulation. Kinetic considerations. Biochem. J. 239, 757\u2013762 (1986).","journal-title":"Biochem. J."},{"key":"BFsrep32036_CR49","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1021\/bi00723a006","volume":"13","author":"K Fujikawa","year":"1974","unstructured":"Fujikawa, K., Coan, M. H., Legaz, M. E. & Davie, E. W. The mechanism of activation of bovine factor X (Stuart factor) by intrinsic and extrinsic pathways. Biochemistry 13, 5290\u20135299 (1974).","journal-title":"Biochemistry"},{"key":"BFsrep32036_CR50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/B978-0-12-385504-6.00002-6","volume":"99","author":"T Z\u00f6gg","year":"2011","unstructured":"Z\u00f6gg, T. & Brandstetter, H. Complex assemblies of FIX and FX regulate the initiation, maintainance and shut down of blood coagulation. Prog. Mol. Biol. Transl. Sci. 99, 51\u2013103 (2011).","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"BFsrep32036_CR51","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.1016\/S0021-9258(19)49685-3","volume":"267","author":"H Takeya","year":"1992","unstructured":"Takeya, H. et al. Coagulation factor X activating enzyme from Russell\u2019s viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains. J. Biol. Chem. 267, 14109\u201314117 (1992).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR52","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/S0021-9258(19)69627-4","volume":"256","author":"G Van Dieijen","year":"1981","unstructured":"Van Dieijen, G., Tans, G., Rosing, J. & Hemker, H. C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256, 3433\u20133442 (1981).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR53","doi-asserted-by":"crossref","first-page":"16126","DOI":"10.1074\/jbc.271.27.16126","volume":"271","author":"RJ Baugh","year":"1996","unstructured":"Baugh, R. J. & Krishnaswamy, S. Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex. J. Biol. Chem. 271, 16126\u201316134 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR54","doi-asserted-by":"crossref","first-page":"23247","DOI":"10.1074\/jbc.M111.251769","volume":"286","author":"N Tavoosi","year":"2011","unstructured":"Tavoosi, N. et al. Molecular determinants of phospholipid synergy in blood clotting. J. Biol. Chem. 286, 23247\u201323253 (2011).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1110\/ps.073016308","volume":"17","author":"RQ Monteiro","year":"2008","unstructured":"Monteiro, R. Q., Rezaie, A. R., Bae, J. S., Calvo, E., Andersen, J. F. & Francischetti, I. M. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci. 17, 146\u2013153 (2008).","journal-title":"Protein Sci"},{"key":"BFsrep32036_CR56","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jmb.2006.11.040","volume":"366","author":"MT Murakami","year":"2007","unstructured":"Murakami, M. T., Rios-Steiner, J., Weaver, S. E., Tulinsky, A., Geiger, J. H. & Arni, R. K. Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum. J Mol Biol. 366, 602\u2013610 (2007).","journal-title":"J Mol Biol."},{"key":"BFsrep32036_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40560-016-0144-5","volume":"4","author":"M Ieko","year":"2016","unstructured":"Ieko, M., Naitoh, S., Yoshida, M. & Takahashi, N. Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences. J Intensive Care. 4, 19 (2016).","journal-title":"J Intensive Care"},{"key":"BFsrep32036_CR58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1182\/blood.V94.2.621","volume":"94","author":"JS Joseph","year":"1999","unstructured":"Joseph, J. S., Chung, M. C., Jeyaseelan, K. & Kini, R. M. Amino acid sequence of trocarin, a prothrombin activator from Tropidechis carinatus venom: its structural similarity to coagulation factor Xa. Blood 94, 621\u2013631 (1999).","journal-title":"Blood"},{"key":"BFsrep32036_CR59","first-page":"73","volume":"109","author":"AJ Quick","year":"1935","unstructured":"Quick, A. J. The prothrombin time in haemophilia and in obstructive jaundice. J. Biol. Chem. 109, 73\u201374 (1935).","journal-title":"J. Biol. Chem."},{"key":"BFsrep32036_CR60","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-93-22823","volume":"93","author":"C Hougie","year":"1956","unstructured":"Hougie, C. Effect of Russell\u2019s viper venom (stypven) on Stuart clotting defect. Proc. Soc. Exp. Biol. Med. 93, 570\u2013573 (1956).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"BFsrep32036_CR61","first-page":"45","volume":"50","author":"RT Jim","year":"1957","unstructured":"Jim, R. T. A study of the plasma thrombin time. J. Lab Clin. Med. 50, 45\u201360 (1957).","journal-title":"J. Lab Clin. Med."},{"key":"BFsrep32036_CR62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ajcp\/36.3.212","volume":"36","author":"RR Proctor","year":"1961","unstructured":"Proctor, R. R. & Rapaport, S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am. J. Clin. Pathol. 36, 212\u2013219 (1961).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFsrep32036_CR63","first-page":"430","volume":"13","author":"CW Pratt","year":"1992","unstructured":"Pratt, C. W. & Monroe, D. M. Microplate coagulation assays. Biotechniques 13, 430\u2013433 (1992).","journal-title":"Biotechniques"},{"key":"BFsrep32036_CR64","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1021\/bi973050y","volume":"37","author":"Y Zhang","year":"1998","unstructured":"Zhang, Y., Ribeiro, J. M., Guimar\u00e3es, J. A. & Walsh, P. N. Nitrophorin-2: a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex. Biochemistry 37, 10681\u201310690 (1998).","journal-title":"Biochemistry"},{"key":"BFsrep32036_CR65","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/bi00829a048","volume":"8","author":"C Huang","year":"1969","unstructured":"Huang, C. Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry 8, 344\u2013352 (1969).","journal-title":"Biochemistry"},{"key":"BFsrep32036_CR66","unstructured":"Silverman, R. B. Kinetics of enzyme inhibition in The organic chemistry of enzyme-catalyzed reactions (2nd edn.) 570\u2013586 (Academic press, 2002)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32036","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T21:10:07Z","timestamp":1672866607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,25]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,10,17]]}},"alternative-id":["BFsrep32036"],"URL":"https:\/\/doi.org\/10.1038\/srep32036","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,25]]},"assertion":[{"value":"13 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32036"}}